Executive Chairman of the Board of Directors · Emergent BioSolutions Inc. (EBS)

Fuad El-Hibri

A named executive officer of Emergent BioSolutions in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,213,484

Salary $1,192,202Stock awards $1,200,046

FY2019: $3,010,062

2nd of 5 named executive officers at Emergent BioSolutions by FY2020 total.

5 named officers on file for Emergent BioSolutions, FY2020

Fuad El-Hibri’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • EBS’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Emergent BioSolutions’s whole pay program stands against its peers

  • Emergent BioSolutions’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EBS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 9, 2021 (DEF 14A).

Free

Get Fuad El-Hibri’s full pay file as a PDF — free

More than this page: up to 10 years of Fuad’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Fuad El-Hibri compensation by year

Emergent BioSolutions Summary Compensation Table · all 5 fiscal years held
In US dollars, as Emergent BioSolutions reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$963,606$1,023,954$1,047,031$1,131,577$1,192,202
Bonus$0$0$0$0$0
Stock awards$899,979$899,971$957,456$1,099,949$1,200,046
Option awards$557,393$635,307$957,481$773,813$815,051
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$7,950$8,250$8,250$4,723$6,185
Total$2,428,928$2,567,482$2,970,218$3,010,062$3,213,484

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Emergent BioSolutions Inc. DEF 14A filed April 9, 2021, accession 0001367644-21-000061, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Emergent BioSolutions Inc. filed document, accession 0001367644-21-000061. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2021.

$2.4M
$2.6M
$3.0M
$3.0M
$3.2M
FY16
FY17
FY18
FY19
FY20
SalaryStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU19,532$1,750,067—
RSU12,019$1,076,902—
RSU6,429$576,038—
Option12,859—$49.64
Option24,047—$61.01
Option39,061—$61.44

Per the Outstanding Equity Awards at Fiscal Year-End table in Emergent BioSolutions Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Emergent BioSolutions’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Robert KramerPresident and Chief Executive Officer$5,569,978
Fuad El-Hibri · this pageExecutive Chairman of the Board of Directors$3,213,484
Richard LindahlExecutive Vice President, Chief Financial Officer and Treasurer$2,281,300
Adam HaveyExecutive Vice President, Business Operations$2,175,528
Atul SaranExecutive Vice President, Corporate Development, General Counsel and Secretary$2,159,032

The full Emergent BioSolutions compensation record

free company brief

This page is one person within Emergent BioSolutions's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Emergent BioSolutions proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Emergent BioSolutions's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Fuad El-Hibri's compensation dossier · One-time report. No refunds.